Journal article
International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting
Journal of drugs in dermatology, v 23(12), pp 1114-1120
01 Dec 2024
PMID: 39630678
Abstract
Background: International Dermatology Outcome Measures (IDEOM) is a non-profit organization whose mission is to improve the availability of evidence-based, consensus-driven outcome measures for dermatological diseases. IDEOM facilitates collaboration between stakeholders from various backgrounds, including researchers, patients, physicians, and industry representatives, to develop objective benchmark metrics that enable better treatment and management of dermatologic conditions.
Summary: The 2023 IDEOM Annual Meeting was held June 23-24, 2023. Workgroups in psoriatic disease, hidradenitis suppurative, geriatric dermatology, connective tissue disease, vitiligo, itch, actinic keratosis, acne, and cutaneous T-cell lymphoma discussed the progress of their respective outcome-measures research. This report summarizes each workgroup's updates since the 2022 annual meeting and their next steps as established during the 2023 IDEOM Annual Meeting.
Metrics
1 Record Views
Details
- Title
- International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting
- Creators
- Arianna J. Zhang - Brigham and Women's HospitalGretchen Ball - College Station Medical CenterMelissa P. Zundell - College Station Medical CenterRosario Aguero - College Station Medical CenterDanielle Yee - College Station Medical CenterAli Shields - Drexel UniversityChristina Asare - University of WashingtonKristina Navrazhina - College Station Medical CenterWinston Liu - Duke UniversityNegar Foolad - Duke UniversityJeffery Kwock - Duke UniversityPriyanka Tejwani - Duke UniversityHassan Hamade - College Station Medical CenterTarannum Jaleel - Duke UniversityDaniel Butler - University of ArizonaNanette Silverberg - College Station Medical CenterLeigh Nattkemper - University of MiamiDaniel M. SiegelJerry Tan - Western Univ Canada, Schulich Sch Med & Dent, London, ON, CanadaBrian S. Kim - College Station Medical CenterCecilia Larocca - Brigham and Women's HospitalMichi M. Shinohara - University of WashingtonAthena Ehlert - Int Dermatol Outcome Measures, Roseville, CA USAJohn Latella - Int Dermatol Outcome Measures, Roseville, CA USAEmma Guttman-YasskyJames G. Krueger - Rockefeller UniversityVibeke Strand - Stanford UniversityApril Armstrong - College Station Medical CenterJoseph F. Merola - Brigham and Women's HospitalLourdes Perez-Chada - Brigham and Women's HospitalAlice B. Gottlieb - College Station Medical Center
- Publication Details
- Journal of drugs in dermatology, v 23(12), pp 1114-1120
- Publisher
- Journal Of Drugs In Dermatology
- Number of pages
- 7
- Grant note
- Pfizer Skin of Color Society Skin of Color Society Foundation IDEOM HS IDEOM grant Kyowa Kirin National Psoriasis Foundation Group for Research and Assessment for Psoriasis and Psoriatic Arthritis K12HD043446 / NIH K12; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA F30DK122712; T32TR004418 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Dermatology
- Web of Science ID
- WOS:001518767400015
- Scopus ID
- 2-s2.0-85211688599
- Other Identifier
- 991022202504704721